Literature DB >> 1234504

A general equation for the ratio of the areas below the blood or plasma concentration time-curves following intravenous and oral drug administration and its application to inter-subject variations in drug elimination.

D P Vaughan, A Trainor.   

Abstract

1 When a drug is metabolized in the liver the total area under the plasma or blood concentration-time curve following oral drug administration is less than the area obtained after intravenous drug administration. This difference has been termed the 'first-pass effect'. 2 General equations for the areas below the blood or plasma concentration-time curve of a drug following intravenous and oral drug administration are derived. 3 An explicit expression for the ratio of areas below the blood or plasma concentration-time curves following intravenous and oral drug administration is derived. 4 By the application of the derived equations it is shown that the relative contribution of hepatic drug metabolism and urinary excretion to inter-subject variation in drug elimination can be easily ascertained.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234504      PMCID: PMC1402568          DOI: 10.1111/j.1365-2125.1975.tb01582.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Concept of a volume of distribution and possible errors in evaluation of this parameter.

Authors:  S Riegelman; J Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

2.  Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs.

Authors:  R N Boyes; H J Adams; B R Duce
Journal:  J Pharmacol Exp Ther       Date:  1970-07       Impact factor: 4.030

3.  Influence of the route of administration on the area under the plasma concentration-time curve.

Authors:  P A Harris; S Riegelman
Journal:  J Pharm Sci       Date:  1969-01       Impact factor: 3.534

4.  Influence of first-pass effect on availability of drugs on oral administration.

Authors:  M Gibaldi; R N Boyes; S Feldman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

5.  Pharmacokinetics of pentazocine in the rhesus monkey.

Authors:  K A Pittman; G A Portmann
Journal:  J Pharm Sci       Date:  1974-01       Impact factor: 3.534

6.  An analysis of the inter-subject variation in the metabolism of pentazocine.

Authors:  D P Vaughan; A H Beckett
Journal:  J Pharm Pharmacol       Date:  1974-10       Impact factor: 3.765

7.  Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.

Authors:  B Alexanderson; D A Evans; F Sjöqvist
Journal:  Br Med J       Date:  1969-12-27
  7 in total
  4 in total

Review 1.  Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

Authors:  D P Vaughan; I Hope
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

2.  A model-independent proof of Dost's law of corresponding areas.

Authors:  D P Vaughan
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

3.  Estimating reduced availability due to first pass elimination from relative total clearance and renal clearance.

Authors:  D Brockmeier
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.